Diabetes Clinical Trials in Atlanta

Showing 361-380 of 621 trials

T1 Diabetes Hypoglycemia Prevention Pilot

NCT02682940

A single center pilot study assessing the Vigilant Diabetes Management System for the prevention of recurrent mild to moderate hypoglycemia in type I diabetes patients.

Diabetes Mellitus, Type 1Hypoglycemia

InSpark Technologies, Inc.4 participantsStarted May 2016

Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

NCT01128894

This open-label study examines the efficacy and safety of albiglutide as compared with liraglutide in subjects with type 2 diabetes.

Diabetes Mellitus, Type 2

GlaxoSmithKline841 participantsStarted May 2010

Birmingham, Alabama, United States • Chandler, Arizona, United States • Gilbert, Arizona, United States +170 more locations

T1 Diabetes Hypoglycemia Prevention Pilot

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Diabetes Trials in Other Cities

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Add Glucokinase Activator to Target A1c

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Other Conditions in Atlanta